Meridian Biopharmaceuticals is dedicated to develop innovative cancer immune therapy drugs. Cancer is
one of the leading causes of death in the developed countries and the second major killer worldwide.
In particular, metastatic disease stages of cancer are not (or not sufficiently) amenable to standard
cancer therapy such as surgery, radiotherapy or chemotherapy, and are responsible for the majority of
deaths of cancer patients.